NEW MEDICINE FOR NEUROBLASTOMA

Early day motion 1531, tabled 17 July 2018 by Jim Shannon (DUP). Signed by 35 members.

That this House welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend dinutuximab beta for the treatment of children with high-risk neuroblastoma; praises the collaborative and flexible approach of all parties including NICE, EUSA Pharma, Solving Kids' Cancer, Neuroblastoma UK, the Children's Cancer and Leukaemia group, JACK, the Bradley Lowery Foundation, Hugs from Henry, Christopher's Smile, Niamh's Next Steps and Smile with Siddy, Grace Kelly Ladybird Trust, Rupert's Revenge Trust, Stacey's Smiles, Harvey Hext Trust, George and the Giant Pledge and Abbie's Army; notes the dedication and involvement of the clinical community in supporting the appraisal process; and calls on the House to praise the bravery of all those children suffering from high-risk neuroblastoma in the UK today.

Signatures by party: Labour 14, DUP 7, Scottish National Party 6, Conservative 4, Independent 1, Labour/Co-operative 1, Liberal Democrat 1, Plaid Cymru 1.